Beyond axonal transection: Hippocampal damage in multiple sclerosis

Annals of Neurology

Volumn 69, Issue 3, 2011, Pages 433-436

  Aktas, Orhan ^a   Hartung, Hans Peter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; CELL DEATH; COGNITIVE DEFECT; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; MULTIPLE SCLEROSIS; NEOCORTEX; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SYNAPTIC TRANSMISSION;

AXONS; HIPPOCAMPUS; HUMANS; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED;

EID: 79953282522     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22409     Document Type: Review

References (38)

1. Hauser SL, Oksenberg JR,. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006; 52: 61-76. (Pubitemid 44466355)
2. Trapp BD, Nave KA,. Multiple sclerosis: an immune or neurodegenerative disorder?. Annu Rev Neurosci 2008; 31: 247-269.
3. Ferguson B, Matyszak MK, Esiri MM, Perry VH,. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120: 393-399. (Pubitemid 27153632)
4. Trapp BD, Peterson J, Ransohoff RM, etal. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-285. (Pubitemid 28065253)
5. Lassmann H,. Multiple sclerosis pathology: evolution of pathogenetic concepts. Brain Pathol 2005; 15: 217-222. (Pubitemid 41161177)
6. Peterson JW, Bo L, Mork S, etal. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50: 389-400. (Pubitemid 32848742)
7. Vercellino M, Plano F, Votta B, etal. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005; 64: 1101-1107.
8. Wegner C, Esiri MM, Chance SA, etal. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006; 67: 960-967. (Pubitemid 44454585)
9. Kutzelnigg A, Lucchinetti CF, Stadelmann C, etal. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705-2712. (Pubitemid 41552953)
10. Rao SM, Leo GJ, Bernardin L, Unverzagt F,. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991; 41: 685-691.
11. Chiaravalloti ND, DeLuca J,. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7: 1139-1151.
12. Dutta R, Chang A, Doud MK, etal. Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients. Ann Neurol 2011; 69: 445-454.
13. Geurts JJ, Bo L, Roosendaal SD, etal. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 2007; 66: 819-827. (Pubitemid 47360957)
14. Roosendaal SD, Moraal B, Vrenken H, etal. In vivo MR imaging of hippocampal lesions in multiple sclerosis. J Magn Reson Imaging 2008; 27: 726-731. (Pubitemid 351508085)
15. Anderson VM, Fisniku LK, Khaleeli Z, etal. Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study. Mult Scler 2010; 16: 1083-1090.
16. Roosendaal SD, Hulst HE, Vrenken H, etal. Structural and functional hippocampal changes in multiple sclerosis patients with intact memory function. Radiology 2010; 255: 595-604.
17. Gold SM, Kern KC, O'Connor MF, etal. Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms. Biol Psychiatry 2010; 68: 553-559.
18. Benedict RH, Ramasamy D, Munschauer F, etal. Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry 2009; 80: 201-206.
19. Papadopoulos D, Dukes S, Patel R, etal. Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. Brain Pathol 2009; 19: 238-253.
20. Coebergh JA, Roosendaal SD, Polman CH, etal. Acute severe memory impairment as a presenting symptom of multiple sclerosis: a clinical case study with 3D double inversion recovery MR imaging. Mult Scler 2010; 16: 1521-1524.
21. Bellmann-Strobl J, Wuerfel J, Aktas O, etal. Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis. Neurology 2009; 73: 1624-1627.
22. Uttner I, Muller S, Zinser C, etal. Reversible impaired memory induced by pulsed methylprednisolone in patients with MS. Neurology 2005; 64: 1971-1973. (Pubitemid 40800721)
23. Kempermann G, Wiskott L, Gage FH,. Functional significance of adult neurogenesis. Curr Opin Neurobiol 2004; 14: 186-191. (Pubitemid 38479935)
24. Monje ML, Toda H, Palmer TD,. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003; 302: 1760-1765. (Pubitemid 37505739)
25. Zamvil SS, Steinman L,. Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis. Neuron 2003; 38: 685-688. (Pubitemid 36694776)
26. Huehnchen P, Prozorovski T, Klaissle P, etal. Modulation of adult hippocampal neurogenesis during myelin-directed autoimmune neuroinflammation. Glia 2011; 59: 132-142.
27. Ziehn MO, Avedisian AA, Tiwari-Woodruff S, Voskuhl RR,. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE. Lab Invest 2010; 90: 774-786.
28. Aktas O, Kieseier B, Hartung HP,. Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis. Trends Neurosci 2010; 33: 140-152.
29. Filippi M, Rocca MA, Benedict RH, etal. The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 2010; 75: 2121-2128.
30. Filippi M, Rocca MA, Calabrese M, etal. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology 2010; 75: 1988-1994.
31. Rudick RA, Polman CH,. Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis. Lancet Neurol 2009; 8: 545-559.
32. Krupp LB, Christodoulou C, Melville P, etal. Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 2004; 63: 1579-1585. (Pubitemid 39507572)
33. Doraiswamy PM, Rao SM,. Treating cognitive deficits in multiplesclerosis: are we there yet?. Neurology 2004; 63: 1552-1553. (Pubitemid 39507565)
34. Villoslada P, Arrondo G, Sepulcre J, etal. Memantine induces reversible neurologic impairment in patients with MS. Neurology 2009; 72: 1630-1633.
35. Lovera JF, Frohman E, Brown TR, etal. Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial. Mult Scler 2010; 16: 715-723.
36. Rocca MA, Valsasina P, Absinta M, etal. Default-mode network dysfunction and cognitive impairment in progressive MS. Neurology 2010; 74: 1252-1259.
37. Loitfelder M, Fazekas F, Petrovic K, etal. Reorganization in cognitive networks with progression of multiple sclerosis: Insights from fMRI. Neurology 2011; 76: 526-533.
38. Sumowski JF, Wylie GR, DeLuca J, Chiaravalloti N,. Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve. Brain 2010; 133: 362-374.